Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
V. Moreno, M.E. Valencia.
Endocarditis fúngica.
eds. Micosis Sistémicas. Actualización (1ª ed), pp. 219-237
[2.]
A. Menasalvas, E. Bouza.
Endocarditis infecciosa por microorganismos poco frecuentes.
Rev Esp Cardiol, 51 (1998), pp. 79-85
[3.]
E. Rubinstein, E.R. Noriega, M.S. Simberkoff, R. Holzman, J.J. Jr. Rahal.
Fungal endocarditis: análisis of 24 cases and review of the literature.
Medicine (Baltimore), 54 (1975), pp. 331-344
[4.]
D.D. Muehrcke, B.W. Lytle, D.M. Cosgrove III.
Surgical and long-term antifungal therapy for fungal prosthetic valve endocarditis.
Ann Thorac Surg, 60 (1995), pp. 538-543
[5.]
P.D. Stein, A.T. Folkens, K.A. Hruska.
Saccharomyces fungemia.
Chest, 58 (1970), pp. 173-175
[6.]
P. Úbeda, A. Viudes, C. Pérez-Bellés, J.L. Marqués, J. Pemán, M. Gobernado, et al.
Endocarditis por Saccharomyces cerevisiae sobre vávula protésica.
Enferm Infecc Microbiol Clin, 18 (2000), pp. 142
[7.]
C.F. Von Reyn, B.S. Levy, R.D. Arbeit, G. Friedland, C.S. Crumpacker.
Infective endocarditis: an analysis based on strict case definitions.
Ann Intern Med, 94 (1981), pp. 505-517
[8.]
D.T. Durack, A.S. Lukes, D.K. Bright.
and the Duke Endocarditis Service. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings.
Amer J Med, 96 (1994), pp. 200-209
[9.]
J.J. Jr. Weems.
Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility.
Clin Infect Dis, 14 (1992), pp. 756-766
[10.]
A. Darwazah, G. Berg, B. Faris.
Candida parapsilosis: an unusual organism causing prosthetic heart valve infective endocarditis.
J Infect, 38 (1999), pp. 130-131
[11.]
D.J. Diekema, S.A. Mecer, R.J. Hollis, R.P. Wenzel, M.A. Pfaller.
An outbreak of Candida parapsilosis prosthetic valve endocarditis.
Diagn Microbiol Infect Dis, 29 (1997), pp. 147-153
[12.]
B.L. Johnston, W.F. Schlech III, T.J. Marie.
An outbreak of Candida parapsilosis prosthetic valve endocarditis following cardiac surgery.
J Hospital Infect, 28 (1994), pp. 103-112
[13.]
J. Romero-Vivas, A. Sánchez-Sousa, M. Rodríguez-Creixems, C. Franco, T. Hellín, F. Parras, et al.
Endocarditis por Candida parapsilosis.
Med Clin (Barc), 84 (1985), pp. 618-619
[14.]
Gilbert DN, Moellering RC, Sande MA. The Sanford guide to antimicrobial therapy (29aed). Antimicrobial Therapy, Inc, 1999
[15.]
J.N. Aucott, J. Fayen, H. Grossnicklas, A. Morrissey, M.M. Lederman, R.A. Salata.
Invasive infection with Saccharomyces cerevisiae: report of three cases and review.
Rev Infect Dis, 12 (1990), pp. 406-411
[16.]
L.P. Longman, S.A. Hibbert, M.V. Martin.
Efficacy of fluconazole in prophylaxis and treatment of experimental Candida endocarditis.
Rev Infect Dis, 16 (1990), pp. 794-798
[17.]
J. Bille, M.P. Glauser, et al.
Evaluation of the susceptibility of pathogenic Candida species to fluconazole.
Eur J Clin Microbiol Infet Dis, 16 (1997), pp. 924-928
[18.]
J. Pemán, E. Cantón, A. Orero, P. Úbeda, A. Viudes, A. Pastor, et al.
Actividad in vitro de fluconazol sobre Candida albicans aisladas de hemocultivos.
Rev Esp Quimioterapia, 11 (1998), pp. 339-343
[19.]
E. Cantón, J. Pemán, A. Carrillo-Muñoz, A. Orero, P. Úbeda, A. Viudes, et al.
Fluconazole susceptibilities of bloodstream Candida sp. isolates as determined by National Conmittee for Clinical Laboratory Standards Method M27-A and two other methods.
J Clin Microbiol, 37 (1999), pp. 2.197-2.200
[20.]
M.H. Nguyen, Ml Nguyen, V.L. Yu, D. McMahon, T.F. Keys, M. Amidi.
Candida prosthetic valve endocarditis: prospective study of six cases and review of the literature.
Clin Infect Dis, 22 (1996), pp. 262-267
[21.]
T. Lejko-Zupanc, M. Kozělj.
A case of recurrent Candida parapsilosis prosthetic valve endocarditis: cure by medical treatment alone.
J Infect, 35 (1997), pp. 81-82
[22.]
L.M. Baddour.
Long-term suppressive therapy for Candida parapsilosis-induced prosthetic valve endocarditis.
Mayo Clin Proc, 70 (1995), pp. 773-775
Copyright © 2001. Elsevier España, S.L.. Todos los derechos reservados
